Skip to search formSkip to main contentSkip to account menu

Recurrent Digestive System Carcinoma

Known as: Recurrent Gastrointestinal System Cancer, Recurrent Gastrointestinal System Carcinoma 
The reemergence of carcinoma in any part of the digestive system after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background Biomarkers in serum may have important clinical implications for personalized medicine, including therapeutic guidance… 
2016
2016
PurposesTo determine the maximum tolerated dose (MTD), recommended dose (RD), and activity of combined oxaliplatin, irinotecan… 
2014
2014
OBJECTIVE We investigated whether objective evaluation by using the palliative prognostic index(PPI), controlling nutritional… 
2014
2014
  • B. Han, H. Kim, D. Zang
  • Annals of oncology : official journal of the…
  • 2014
  • Corpus ID: 1346686
ABSTRACT Aim: To determine the maximum tolerated dose (MTD), recommended dose (RD), and activity of combined oxaliplatin… 
2013
2013
Background:The clinical significance of circulating tumour cell (CTC) detection in gastrointestinal (GI) cancer remains… 
2010
2010
The aim of this study was to introduce an oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer… 
2004
2004
2615 Background: Immunotherapy with tumor cell-dendritic cell fusion vaccine has been shown to induce the immune response against… 
2004
2004
2615 Background: Immunotherapy with tumor cell-dendritic cell fusion vaccine has been shown to induce the immune response against… 
1990
1990
Early phase II study in patients with advanced and recurrent gastrointestinal cancer was conducted from August 1986 through…